Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development
Abstract Despite increasing interest in using Artificial Intelligence (AI) and Machine Learning (ML) models for drug development, effectively interpreting their predictions remains a challenge, which limits their impact on clinical decisions. We address this issue by providing a practical guide to S...
Saved in:
| Main Authors: | Ana Victoria Ponce‐Bobadilla, Vanessa Schmitt, Corinna S. Maier, Sven Mensing, Sven Stodtmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease
by: Sagar S. Bachhav, et al.
Published: (2025-07-01) -
Explainable Machine Learning: A SHAP value-based approach to locational frequency stability
by: Alinane B. Kilembe, et al.
Published: (2025-09-01) -
Shap‐Cov: An Explainable Machine Learning Based Workflow for Rapid Covariate Identification in Population Modeling
by: Logan Brooks, et al.
Published: (2025-08-01) -
A Perspective on Explainable Artificial Intelligence Methods: SHAP and LIME
by: Ahmed M. Salih, et al.
Published: (2025-01-01) -
Raman Spectra Classification of Pharmaceutical Compounds: A Benchmark of Machine Learning Models with SHAP-Based Explainability
by: Dimitris Kalatzis, et al.
Published: (2025-07-01)